Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
SJO-Saudi Journal of Ophthalmology. 2013; 27 (2): 121-123
Dans Anglais | IMEMR | ID: emr-130187

Résumé

A patient having monocular elevation deficiency with associated dextrocardia and situs inversus is reported. Review of the literature regarding ocular features described in association with dextrocardia is also presented


Sujets)
Humains , Mâle , Situs inversus/diagnostic , Syndrome de Moebius
2.
The Medical Journal of Malaysia ; : 176-177, 2004.
Article Dans Malayalam | WPRIM | ID: wpr-629952

Résumé

Biomaterials intended for end-use application as bone-graft substitutes have to undergo safety evaluation. In this study, we investigated the in vitro cytotoxic effects especially to determine the mode of death of two hydroxyapatite compounds (HA2, HA3) which were synthesized locally. The methods used for cytotoxicity was the standard MTT assay whereas AO/PI staining was performed to determine the mode of cell death in HA treated L929 fibroblasts. Our results demonstrated that both HA2 and HA3 were not significantly cytotoxic as more than 75% cells after 72 hours treatment were viable. Furthermore, we found that the major mode of cell death in HA treated cells was apoptosis. In conclusion, our results demonstrated that these hydroxyapatite compounds are not cytotoxic where the mode of death was primarily via apoptosis.


Sujets)
Apoptose/effets des médicaments et des substances chimiques , Matériaux biocompatibles/toxicité , Substituts osseux/toxicité , Mort cellulaire/effets des médicaments et des substances chimiques , Durapatite/toxicité , Cellules L (lignée cellulaire) , Prothèses et implants
3.
The Medical Journal of Malaysia ; : 170-171, 2004.
Article Dans Malayalam | WPRIM | ID: wpr-629950

Résumé

Hydroxyapatite is the main component of the bone which is a potential biomaterial substance that can be applied in orthopaedics. In this study, the biocompatibility of this biomaterial was assessed using an in vitro technique. The cytotoxicity and genotoxicity effect of HA2 and HA3 against L929 fibroblast cell was evaluated using the MTT Assay and Alkaline Comet Assay respectively. Both HA2 and HA3 compound showed low cytotoxicity effect as determined using MTT Assay. Cells viability following 72 hours incubation at maximum concentration of both HA2 and HA3 (200 mg/ml) were 75.3 +/- 8.8% and 86.7 +/- 13.1% respectively. However, the cytotoxicity effect of ZnSO4.7H2O as a positive control showed an IC50 values of 46 mg/ml (160 microM). On the other hand, both HA2 and HA3 compound showed a slight genotoxicity effect as determined using the Alkaline Comet Assay following incubation at the concentration 200 mg/ml for 72 hours. This assay has been widely used in genetic toxicology to detect DNA strand breaks and alkali-labile site. The percentage of the cells with DNA damage for both substance was 27.7 +/- 1.3% and 15.6 +/- 1.0% for HA2 and HA3 respectively. Incubation of the cells for 24 hours with 38 microg/ml (IC25) of positive control showed an increase in percentage of cells with DNA damage (67.5 +/- 0.7%). In conclusion, our study indicated that both hydroxyapatite compounds showed a good biocompatibility in fibroblast cells.


Sujets)
Matériaux biocompatibles/toxicité , Substituts osseux/toxicité , Survie cellulaire/effets des médicaments et des substances chimiques , Altération de l'ADN , Hydroxyapatites/toxicité , Cellules L (lignée cellulaire) , Tests de mutagénicité , Prothèses et implants
SÉLECTION CITATIONS
Détails de la recherche